{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T09:28:38Z","timestamp":1794907718238,"version":"4.9.1"},"reference-count":35,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,9,2]],"date-time":"2008-09-02T00:00:00Z","timestamp":1220313600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:p>\n                    <jats:bold>Background.\u2014<\/jats:bold>\n                    Though symptomatic medication overuse is believed to play a major role in progression from episodic to chronic or transformed migraine (TM), population\u2010based longitudinal data on these agents are limited.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objectives.\u2014<\/jats:bold>\n                    To assess the role of specific classes of acute medications in the development of TM in episodic migraine (EM) sufferers after adjusting for other risk factors for headache progression.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods.\u2014<\/jats:bold>\n                    As a part of the American Migraine Prevalence and Prevention study (AMPP), we initially surveyed a population sample of 120,000 individuals to identify a sample of migraineurs to be followed annually over 5 years. Using logistic and linear regression, we modeled the probability of transition from EM in 2005 to TM in 2006 in relation to medication use status at baseline. Adjustments were made for gender, headache frequency and severity, and prevention medication use.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.\u2014<\/jats:bold>\n                    Of 8219 individuals with EM in 2005, 209 (2.5%) had developed TM by 2006. Baseline headache frequency was a risk factor for TM. Using acetaminophen user as the reference group, individuals who used medications containing barbiturates (OR\u2003=\u20032.06, 95%CI\u2003=\u20031.3\u20103.1) or opiates (OR\u2003=\u20031.98, 95%CI\u2003=\u20031.4\u20102.2) were at increased risk of TM. A dose\u2013response relationship was found for use of barbiturates. Use of triptans (OR\u2003=\u20031.25, 95%CI\u2003=\u20030.9\u20101.7) at baseline was not associated with prospective risk of TM. Overall, NSAIDs (OR\u2003=\u20030.85, 95%CI\u2003=\u20030.63\u20101.17) were not associated with TM. Indeed, NSAIDs were protective against transition to TM at low to moderate monthly headache days, but were associated with increased risk of transition to TM at high levels of monthly headache days.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion.\u2014<\/jats:bold>\n                    EM sufferers develop TM at the rate of 2.5% per year. Any use of barbiturates and opiates was associated with increased risk of TM after adjusting for covariates, while triptans were not. NSAIDs were protective or inducers depending on the headache frequency.\n                  <\/jats:p>","DOI":"10.1111\/j.1526-4610.2008.01217.x","type":"journal-article","created":{"date-parts":[[2008,9,2]],"date-time":"2008-09-02T19:45:01Z","timestamp":1220384701000},"page":"1157-1168","source":"Crossref","is-referenced-by-count":731,"title":["Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population\u2010Based Study"],"prefix":"10.1111","volume":"48","author":[{"given":"Marcelo E.","family":"Bigal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Buse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter F.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,2]]},"reference":[{"issue":"1","key":"e_1_2_5_2_2","first-page":"1","article-title":"Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain","volume":"24","author":"Headache Classification","year":"2004","journal-title":"Cephalalgia"},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.47.4.871","article-title":"Classification of daily and near\u2010daily headaches: Field trial of revised IHS criteria","volume":"47","author":"Silberstein SD","year":"1996","journal-title":"Neurology"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1468-2982.2006.01172.x","article-title":"New appendix criteria open for a broader concept of chronic migraine","volume":"26","author":"Classification H","year":"2006","journal-title":"Cephalalgia"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3959(03)00293-8","article-title":"Factors associated with the onset and remission of chronic daily headache in a population\u2010based study","volume":"106","author":"Scher AI","year":"2003","journal-title":"Pain"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1526-4610.1999.3903190.x","article-title":"Epidemiology of chronic daily headache in the general population","volume":"39","author":"Castillo J","year":"1999","journal-title":"Headache"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1526-4610.1992.hed3209439.x","article-title":"Chronic daily headache: Long\u2010term prognosis following inpatient treatment with repetitive IV DHE","volume":"32","author":"Silberstein SD","year":"1992","journal-title":"Headache"},{"key":"e_1_2_5_8_2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1212\/01.WNL.0000113747.18760.D2","article-title":"Incidence and predictors for chronicity of headache in patients with episodic migraine","volume":"62","author":"Katsarava Z","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"e_1_2_5_9_2","first-page":"S144","article-title":"Modifiable risk factors for migraine progression (or for chronic daily headaches)\u2014clinical lessons","volume":"46","author":"Bigal ME","year":"2006","journal-title":"Headache"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0733-8619(18)30325-6","article-title":"Drug\u2010induced headache","volume":"8","author":"Mathew NT","year":"1990","journal-title":"Neurol Clin"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1468-2982.2004.00691.x","article-title":"Transformed migraine and medication overuse in a tertiary headache centre\u2014clinical characteristics and treatment outcomes","volume":"24","author":"Bigal ME","year":"2004","journal-title":"Cephalalgia"},{"key":"e_1_2_5_12_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1526-4610.1996.3601014.x","article-title":"Analgesic rebound headache in clinical practice: Data from a physician survey","volume":"36","author":"Rapoport A","year":"1996","journal-title":"Headache"},{"key":"e_1_2_5_13_2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1526-4610.2002.02133_2.x","article-title":"Debate: Analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headache","volume":"42","author":"Dodick DW","year":"2002","journal-title":"Headache"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1526-4610.2002.02133_1.x","article-title":"Debate: Analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is a cause of chronic daily headache","volume":"42","author":"Tepper SJ","year":"2002","journal-title":"Headache"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11916-007-0216-2","article-title":"Sensitization, glutamate, and the link between migraine and fibromyalgia","volume":"11","author":"Sarchielli P","year":"2007","journal-title":"Curr Pain Headache Rep"},{"key":"e_1_2_5_16_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1526-4637.2000.99105.x","article-title":"Limbically augmented pain syndrome (LAPS): Kindling, corticolimbic sensitization, and the convergence of affective and sensory symptoms in chronic pain disorders","volume":"1","author":"Rome HP","year":"2000","journal-title":"Pain Med"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton RB","year":"2007","journal-title":"Neurology"},{"key":"e_1_2_5_18_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ana.21211","article-title":"Cutaneous allodynia in the migraine population","volume":"63","author":"Lipton RB","year":"2008","journal-title":"Ann Neurol"},{"key":"e_1_2_5_19_2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1001\/archinte.167.18.1964","article-title":"Body mass index and episodic headaches: A population\u2010based study","volume":"167","author":"Bigal ME","year":"2007","journal-title":"Arch Intern Med"},{"key":"e_1_2_5_20_2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1468-2982.2006.01275.x","article-title":"Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study","volume":"27","author":"Silberstein S","year":"2007","journal-title":"Cephalalgia"},{"issue":"1","key":"e_1_2_5_21_2","first-page":"369","article-title":"Validation of the chronic daily headache questionnaire","volume":"68","author":"Liebestein M","year":"2007","journal-title":"Neurology"},{"key":"e_1_2_5_22_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: Concerns and strategies","volume":"81","author":"Compton WM","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"e_1_2_5_23_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jsat.2005.05.008","article-title":"Charting a course for health services research at the National Institute on drug abuse","volume":"29","author":"Compton WM","year":"2005","journal-title":"J Subst Abuse Treat"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1212\/01.WNL.0000123262.96132.FC","article-title":"Analgesic overuse among subjects with headache, neck, and low\u2010back pain","volume":"62","author":"Zwart JA","year":"2004","journal-title":"Neurology"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1526-4610.2001.111006303.x","article-title":"Opiate use to control bowel motility may induce chronic daily headache in patients with migraine","volume":"41","author":"Wilkinson SM","year":"2001","journal-title":"Headache"},{"key":"e_1_2_5_26_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1526-4610.2003.03041.x","article-title":"Does chronic daily headache arise de novo in association with regular use of analgesics?","volume":"43","author":"Bahra A","year":"2003","journal-title":"Headache"},{"key":"e_1_2_5_27_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1212\/01.wnl.0000223332.35936.6e","article-title":"Medication\u2010overuse headache in patients with cluster headache","volume":"67","author":"Paemeleire K","year":"2006","journal-title":"Neurology"},{"key":"e_1_2_5_28_2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1526-4610.2001.041007629.x","article-title":"Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness?","volume":"41","author":"Welch KMA","year":"2001","journal-title":"Headache"},{"key":"e_1_2_5_29_2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/brain\/123.8.1703","article-title":"The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine","volume":"123","author":"Burstein R","year":"2000","journal-title":"Brain"},{"key":"e_1_2_5_30_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1526-4610.2007.00969.x","article-title":"Concepts and mechanisms of migraine chronification","volume":"48","author":"Bigal ME","year":"2008","journal-title":"Headache"},{"key":"e_1_2_5_31_2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"McGeer PL","year":"2008","journal-title":"Mov Disord"},{"key":"e_1_2_5_32_2","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1212\/01.wnl.0000279519.99344.ad","article-title":"Nonsteroidal anti\u2010inflammatory drugs may protect against Parkinson disease","volume":"69","author":"Wahner AD","year":"2007","journal-title":"Neurology"},{"key":"e_1_2_5_33_2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2007.09.004","article-title":"NSAIDs: Small molecules for prevention of Alzheimer's disease or precursors for future drug development?","volume":"28","author":"Weggen S","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"e_1_2_5_34_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.10786","article-title":"Defeating migraine pain with triptans: A race against the development of cutaneous allodynia","volume":"55","author":"Burstein R","year":"2004","journal-title":"Ann Neurol"},{"key":"e_1_2_5_35_2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuroscience.2007.04.064","article-title":"Sensitization of central trigeminovascular neurons: Blockade by intravenous naproxen infusion","volume":"148","author":"Jakubowski M","year":"2007","journal-title":"Neuroscience"},{"key":"e_1_2_5_36_2","unstructured":"Center for Disease Control and Prevention.Substance Abuse. Available at:http:\/\/www.cdc.gov\/correctionalhealth\/specialtopics.htm. Accessed December 16 2007."}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1526-4610.2008.01217.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1526-4610.2008.01217.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:03:05Z","timestamp":1762084985000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/j.1526-4610.2008.01217.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1526-4610.2008.01217.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4610.2008.01217.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1140847.598930","asserted-by":"object"}]},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}